Hamburg, Germany, 10 June 2016: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) was awarded the European Mediscience Award for best communication. The award was presented to Gabriele Hansen, VP Corporate Communications & Investor Relations at a celebratory dinner on Thursday, 09 June 2016, in London. The European Mediscience Awards is the largest annual gathering of private and publicly quoted healthcare, biotech and life science companies in Europe recognising achievements in the life sciences industry. Evotec is very proud to be awarded with this prestigious award for the second time (2014 and 2016).
For further information on the European Mediscience Award, please click on the following link: http://www.mediscience-event.co.uk/home/.
 
FORWARD LOOKING STATEMENTS — Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.